Nectar Lifesciences Limited (NSE:NECLIFE)

India · Delayed Price · Currency is INR

11.29

-0.42 (-3.59%)

Mar 9, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals Products	16.70B	16.85B	15.24B	16.69B	15.43B
Pharmaceuticals Products Growth	-0.84%	10.56%	-8.70%	8.13%	-34.78%
Total	16.70B	16.85B	15.24B	16.69B	15.43B
Total Growth	-0.84%	10.56%	-8.70%	8.13%	-34.78%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	11.72B	11.46B	8.45B	11.81B	9.66B
India Growth	2.20%	35.61%	-28.42%	22.27%	-43.23%
Outside India	7.37B	7.79B	9.01B	7.45B	7.98B
Outside India Growth	-5.47%	-13.51%	21.05%	-6.69%	-17.87%
Total	19.08B	19.26B	17.47B	19.26B	17.64B
Total Growth	-0.91%	10.26%	-9.29%	9.17%	-34.01%

Source: S&P Global Market Intelligence.